Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice (Q38294946)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice |
scientific article |
Statements
1 reference
Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice (English)
1 reference
Jetton TL
1 reference
Liang Y
1 reference
Cincotta AH
1 reference
1 November 2001
1 reference
1 reference
50
1 reference
11
1 reference
1377-1384
1 reference
Identifiers
1 reference
1 reference